Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

OV8010

Mid-advanced stage ovary cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases/80 cores
Unstained: $255.00 Add to Cart
H&E (OV8010s*): $255.00 Add to Cart

Microarray Panel:Mid-advanced stage ovarial carcinoma tissue microarray, containing 72 cases of adenocarcinoma, 1 clear cell carcinoma, 2 transitional cell carcinoma, 34 cases in mid stage, 41 in advanced stage, 5 metastasis tissue, single core per case
Cores:80
Cases:80
Layout:10 cols × 8 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
12345678910 
A Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
B Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
C Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
D Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
E Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
F Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
G Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
H Ova Ova Ova Ova Ova Lym Lym Lym Lym Lym Marked point
Legend: Lym - Lymph node, Ova - Ovary

- Malignant tumor, - Malignant tumor (stage II), - Malignant tumor (stage III), - Malignant tumor (stage IIIc), - Malignant tumor (stage IIa), - Malignant tumor (stage IIb), - Malignant tumor (stage IIc), - Malignant tumor (stage IV), - Metastasis

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 F 69 Ovary Serous papillary adenocarcinoma 1 IIb T2bN0M0 Malignant
A2 2 F 73 Ovary Serous papillary adenocarcinoma 2 IIa T2aN0M0 Malignant
A3 3 F 60 Ovary Serous papillary adenocarcinoma 2 IIa T2aN0M0 Malignant
A4 4 F 56 Ovary Serous papillary adenocarcinoma 2 II T2N0M0 Malignant
A5 5 F 35 Ovary Serous papillary adenocarcinoma 2 II T2N0M0 Malignant
A6 6 F 49 Ovary Serous papillary adenocarcinoma 2 IIc T2cN0M0 Malignant
A7 7 F 63 Ovary Serous papillary adenocarcinoma 2 IIb T2bN0M0 Malignant
A8 8 F 49 Ovary Serous papillary adenocarcinoma 2 II T2N0M0 Malignant
A9 9 F 60 Ovary Serous papillary adenocarcinoma 2 IIb T2bN0M0 Malignant
A10 10 F 45 Ovary Serous papillary adenocarcinoma 2 II T2N0M0 Malignant
B1 11 F 51 Ovary Serous papillary adenocarcinoma 2 IIa T2aN0M0 Malignant
B2 12 F 65 Ovary Serous papillary adenocarcinoma 2 II T2N0M0 Malignant
B3 13 F 56 Ovary Serous papillary adenocarcinoma 2 II T2N0M0 Malignant
B4 14 F 41 Ovary Serous adenocarcinoma 3 IIc T2cN0M0 Malignant
B5 15 F 56 Ovary Serous adenocarcinoma 3 II T2N0M0 Malignant
B6 16 F 39 Ovary Serous adenocarcinoma with necrosis 3 II T2N0M0 Malignant
B7 17 F 48 Ovary Serous adenocarcinoma 3 IIa T2aN0M0 Malignant
B8 18 F 75 Ovary Serous adenocarcinoma 3 II T2N0M0 Malignant
B9 19 F 43 Ovary Serous adenocarcinoma 3 II T2N0M0 Malignant
B10 20 F 51 Ovary Serous adenocarcinoma 3 IIa T2aN0M0 Malignant
C1 21 F 45 Ovary Serous adenocarcinoma 3 IIb T2bN0M0 Malignant
C2 22 F 59 Ovary Serous adenocarcinoma 3 II T2N0M0 Malignant
C3 23 F 48 Ovary Serous adenocarcinoma 3 IIb T2bN0M0 Malignant
C4 24 F 41 Ovary Mucinous adenocarcinoma 2 IIa T2aN0MO Malignant
C5 25 F 40 Ovary Mucinous papillary adenocarcinoma 2 II T2N0M0 Malignant
C6 26 F 62 Ovary Adenocarcinoma (sparse) – IIa T2aN0M0 Malignant
C7 27 F 50 Ovary Mucinous adenocarcinoma 3 II T2N0M0 Malignant
C8 28 F 41 Ovary Mucinous adenocarcinoma 3 IIa T2aN0M0 Malignant
C9 29 F 60 Ovary Endometrioid adenocarcinoma (sparse) with necrosis – II T2N0M0 Malignant
C10 30 F 50 Ovary Endometrioid adenocarcinoma 2 IIa T2aN0M0 Malignant
D1 31 F 68 Ovary Endometrioid adenocarcinoma 3 IIc T2cN0M0 Malignant
D2 32 F 29 Ovary Adenocarcinoma 3 IIa T2aN0M0 Malignant
D3 33 F 47 Ovary Mucinous adenocarcinoma 3 IIa T2aN0M0 Malignant
D4 34 F 47 Ovary Clear cell carcinoma – IIa T2aN0M0 Malignant
D5 35 F 66 Ovary Serous adenocarcinoma 3 IIIc T3N1M0 Malignant
D6 36 F 52 Ovary Serous papillary adenocarcinoma 2 IIIc T3cN1M0 Malignant
D7 37 F 50 Ovary Serous papillary adenocarcinoma 2 IIIc T3N1M0 Malignant
D8 38 F 54 Ovary Serous papillary adenocarcinoma 2 IIIc T3cN1M0 Malignant
D9 39 F 51 Ovary Serous papillary adenocarcinoma 2 IIIc T3N1M0 Malignant
D10 40 F 58 Ovary Serous papillary adenocarcinoma 2 IV T3N0M1 Malignant
E1 41 F 48 Ovary Serous papillary adenocarcinoma 3 IIIc T3cN0M0 Malignant
E2 42 F 38 Ovary Serous papillary adenocarcinoma 3 IIIc T1bN1m0 Malignant
E3 43 F 57 Ovary Serous papillary adenocarcinoma 3 IIIc T3cN1M0 Malignant
E4 44 F 53 Ovary Serous papillary adenocarcinoma 3 IIIc T3bN1M0 Malignant
E5 45 F 62 Ovary Serous papillary adenocarcinoma 3 III T3N0M0 Malignant
E6 46 F 49 Ovary Serous papillary adenocarcinoma 3 IIIc T3N1M0 Malignant
E7 47 F 65 Ovary Serous papillary adenocarcinoma 3 IIIc T3cN0M0 Malignant
E8 48 F 47 Ovary Serous papillary adenocarcinoma 3 IIIc T3cN1M0 Malignant
E9 49 F 42 Ovary Serous papillary adenocarcinoma 3 IIIc T3cN1M0 Malignant
E10 50 F 46 Ovary Serous papillary adenocarcinoma 3 IIIc T2cN1M0 Malignant
F1 51 F 56 Ovary Serous papillary adenocarcinoma 3 IIIc T3N1M0 Malignant
F2 52 F 56 Ovary Serous papillary adenocarcinoma 3 IIIc T2N1M0 Malignant
F3 53 F 42 Ovary Serous papillary adenocarcinoma 3 IIIc TeN1M0 Malignant
F4 54 F 32 Ovary Serous papillary adenocarcinoma 3 IIIc T3cN0M0 Malignant
F5 55 F 46 Ovary Serous papillary adenocarcinoma 3 IIIc T3aN1M0 Malignant
F6 56 F 26 Ovary Serous papillary adenocarcinoma 3 IIIc T3CN1M0 Malignant
F7 57 F 57 Ovary Serous papillary adenocarcinoma 2 IIIc T3cN1M0 Malignant
F8 58 F 43 Ovary Mucinous papillary adenocarcinoma 1 IIIc T3cN1M0 Malignant
F9 59 F 48 Ovary Mucinous adenocarcinoma 3 IIIc T3cN0M0 Malignant
F10 60 F 52 Ovary Transitional cell carcinoma 3 IIIc T2N1M0 Malignant
G1 61 F 55 Ovary Transitional cell carcinoma 3 IIIc T3cN0M0 Malignant
G2 62 F 66 Ovary Serous papillary adenocarcinoma 2 IV T3N0M1 Malignant
G3 63 F 69 Ovary Serous papillary adenocarcinoma 2 IV T2N0M1 Malignant
G4 64 F 37 Ovary Serous papillary adenocarcinoma 2 IV T3N1M1 Malignant
G5 65 F 65 Ovary Serous papillary adenocarcinoma 2 IV T2aN0M1 Malignant
G6 66 F 54 Ovary Serous papillary adenocarcinoma 2 IV T2aN0M1 Malignant
G7 67 F 55 Ovary Serous papillary adenocarcinoma 2 IV T3cN1M1 Malignant
G8 68 F 56 Ovary Serous papillary adenocarcinoma 2 IV T3cN0M1 Malignant
G9 69 F 56 Ovary Serous papillary adenocarcinoma 2 IV T3cN1M1 Malignant
G10 70 F 48 Ovary Serous adenocarcinoma 2 IV T3N1M1 Malignant
H1 71 F 43 Ovary Serous adenocarcinoma 3 IV T2N0M1 Malignant
H2 72 F 65 Ovary Serous adenocarcinoma 3 IV T2N0M1 Malignant
H3 73 F 41 Ovary Serous adenocarcinoma 3 IV T2aN0M1 Malignant
H4 74 F 51 Ovary Serous adenocarcinoma 3 IV T1N0M1 Malignant
H5 75 F 59 Ovary Endometrioid adenocarcinoma 2–3 IV T2N0M1 Malignant
H6 76 F 59 Lymph node Metastatic serous adenocarcinoma 3 – – Metastasis
H7 77 F 53 Lymph node Metastatic serous adenocarcinoma from omenta 3 – – Metastasis
H8 78 F 55 Lymph node Metastatic serous adenocarcinoma from omenta 2 – – Metastasis
H9 79 F 47 Lymph node Metastatic serous adenocarcinoma 3 – – Metastasis
H10 80 F 54 Lymph node Metastatic serous adenocarcinoma 3 – – Metastasis
– – M 58 Skin Malignant melanoma (tissue marker) – Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal